JIMSMENews

Follow us : Mail

Arvee Laboratories (India)- HY1-FY21 PAT dips at Rs. 71.31 lacs against Rs.1.26 crore in HY1-FY20


Arvee Laboratories (India)– HY1-FY21 revenue at Rs.18.68 crore against Rs. 26.98 crore in HY1-FY20

Company : Arvee Laboratories (India) Limited

Arvee Laboratories (India) declared its standalone financial results for the HY1 ended 30th September, 2020 marking a fall in post-tax gains against the net profit in a year ago period.

Following are the standalone financials at Arvee Laboratories (India) in HY1-FY20-21:

- PAT shrinks at Rs. 71.31 lacs compared to net profit of Rs. 1.26 crore in the corresponding period last year.

- Standalone Earnings per share for the current half year stands at Rs.1.29 as against EPS of Rs.2.30 in previous year same period.

- Revenue stood at Rs.18.68 crore against Rs26.98 crore in a year ago period.

By the end of financial year 2019-20, standalone total revenue at Arvee Laboratories (India) reached Rs.45.76 crore. PAT for FY20 was Rs.2.22 crore and Standalone EPS was Rs.4.04.


Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.